R. Badal

发表

Increasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: data from the SMART study (2009).

R. Bonomo, A. Hujer, M. Hackel, 2011, The Journal of antimicrobial chemotherapy.

Post Syrian war impact on susceptibility rates and trends in molecular characterization of Enterobacteriaceae.

W. Hayajneh, A. Hajj, R. Badal, 2018, Future microbiology.

Global Incidence of Carbapenemase-Producing Escherichia coli ST131

G. Peirano, K. Kazmierczak, M. Hackel, 2014, Emerging infectious diseases.

Antimicrobial susceptibility and extended-spectrum beta-lactamase rates in aerobic gram-negative bacteria causing intra-abdominal infections in Vietnam: report from the Study for Monitoring Antimicrobial Resistance Trends (SMART 2009-2011).

M. Hackel, D. Hoban, T. Nga, 2014, Diagnostic microbiology and infectious disease.

A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011

I. Morrissey, M. Hackel, S. Hawser, 2013, Pharmaceuticals.

Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase-producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009-2010.

L. Nicolle, M. Hackel, D. Hoban, 2012, Diagnostic microbiology and infectious disease.

Low frequency of ertapenem-resistant intra-abdominal isolates of Escherichia coli from Latin America: susceptibility, ESBL-occurrence, and molecular characterisation (SMART 2008–2009)

M. Hackel, F. Rossi, D. Hoban, 2012, Journal of chemotherapy.

Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009-2011.

D. Hoban, S. Hawser, S. Bouchillon, 2013, Clinical therapeutics.

Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010-2014.

K. Kazmierczak, L. Nicolle, D. Hoban, 2016, Diagnostic microbiology and infectious disease.

Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients

B. Cao, Ziyong Sun, Qiwen Yang, 2017, BMC Infectious Diseases.

In Vitro Activity of Imipenem against Carbapenemase-Positive Enterobacteriaceae Isolates Collected by the SMART Global Surveillance Program from 2008 to 2014

K. Kazmierczak, M. Motyl, J. Karlowsky, 2017, Journal of Clinical Microbiology.

Antimicrobial-resistant Pseudomonas aeruginosa and Acinetobacter baumannii From Patients With Hospital-acquired or Ventilator-associated Pneumonia in Vietnam.

R. Badal, D. Biedenbach, Doan Mai Phuong, 2016, Clinical therapeutics.

Incidence and Antimicrobial Susceptibility of Escherichia coli and Klebsiella pneumoniae with Extended-Spectrum β-Lactamases in Community- and Hospital-Associated Intra-Abdominal Infections in Europe: Results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART)

F. Baquero, R. Cantón, D. Hoban, 2010, Antimicrobial Agents and Chemotherapy.

In vitro susceptibility and distribution of beta-lactamases in Enterobacteriaceae causing intra-abdominal infections in North America 2010-2011.

K. Kazmierczak, M. Hackel, D. Hoban, 2014, Diagnostic microbiology and infectious disease.

Epidemiology and antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2008 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

D. Paterson, P. Hsueh, D. Hoban, 2010, International journal of antimicrobial agents.

Susceptibility of Gram-Negative Pathogens Isolated from Patients with Complicated Intra-Abdominal Infections in the United States, 2007-2008: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)

D. Hoban, S. Hawser, S. Bouchillon, 2010, Antimicrobial Agents and Chemotherapy.

Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007.

D. Hoban, S. Hawser, S. Bouchillon, 2010, Diagnostic microbiology and infectious disease.

Antimicrobial susceptibility of global inpatient urinary tract isolates of Escherichia coli: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009-2010.

L. Nicolle, D. Hoban, S. Hawser, 2011, Diagnostic microbiology and infectious disease.

Characterization of extended-spectrum beta-lactamases and antimicrobial resistance of Klebsiella pneumoniae in intra-abdominal infection isolates in Latin America, 2008-2012. Results of the Study for Monitoring Antimicrobial Resistance Trends.

K. Kazmierczak, M. Hackel, D. Hoban, 2015, Diagnostic microbiology and infectious disease.

Using Nucleic Acid Microarrays To Perform Molecular Epidemiology and Detect Novel (cid:1) -Lactamases: a Snapshot of Extended-Spectrum (cid:1) -Lactamases throughout the World

A. Hujer, M. Hackel, D. Hoban, 2012 .

Trends in Susceptibility of Escherichia coli from Intra-Abdominal Infections to Ertapenem and Comparators in the United States According to Data from the SMART Program, 2009 to 2013

K. Kazmierczak, M. Hackel, D. Sahm, 2015, Antimicrobial Agents and Chemotherapy.

Dissemination of NDM Metallo-β-Lactamase Genes among Clinical Isolates of Enterobacteriaceae Collected during the SMART Global Surveillance Study from 2008 to 2012

K. Kazmierczak, M. Hackel, D. Hoban, 2014, Antimicrobial Agents and Chemotherapy.

Susceptibility of gram-negative aerobic bacilli from intra-abdominal pathogens to antimicrobial agents collected in the United States during 2011.

M. Hackel, D. Hoban, D. Goff, 2014, The Journal of infection.

Monitoring the global in vitro activity of ertapenem against Escherichia coli from intra-abdominal infections: SMART 2002-2010.

D. Paterson, R. Cantón, D. Hoban, 2013, International journal of antimicrobial agents.

Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum β-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008-2009).

M. Hackel, R. Cantón, D. Hoban, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

The in Vitro Activity of Tigecycline and Antimicrobial Cross-Resistance Against Enterobacteriaceae Worldwide

M. Hackel, D. Hoban, S. Bouchillon, 2008 .

Bacterial Resistance Patterns of Isolates from Various Body Sites: The European T.E.S.T. Program

M. Hackel, D. Hoban, J. Johnson, 2008 .

Tigecycline and Comparators Against Extended Spectrum Beta-Lactamase (ESBL) Isolates Worldwide

John L. Johnson, M. Hackel, D. Hoban, 2008 .

Evaluation of Tigecycline in the United States Against Antimicrobial Resistant Acinetobacter

M. Hackel, D. Hoban, J. Johnson, 2008 .

An Asia/Pacific Rim Perspective of Enterobacteriaceae Multi-drug Resistant (MDR) Isolates Against Tigecycline

John L. Johnson, M. Hackel, D. Hoban, 2008 .

An Evaluation of Tigecycline and Comparators in Asia/Pacific Rim for Often Difficult to Treat Pathogens

John L. Johnson, M. Hackel, D. Hoban, 2008 .

Evaluation of Tigecycline and Other Antimicrobials in Latin America Against Multi-drug Resistant (MDR) Staphylococcus aureus

John L. Johnson, M. Hackel, D. Hoban, 2008 .

P2051 Antibacterial activity of tigecycline against H. influenzae and S. pneumoniae (2004–06) Global Population –T.E.S.T. Program, 2006

John L. Johnson, M. Hackel, D. Hoban, 2007 .

P1684 Tigecycline in vitro activity against often difficult to treat European pathogens

John L. Johnson, M. Hackel, D. Hoban, 2007 .

P2048 Comparison of in vitro activity of tigecycline against pathogens from intensive care patients in Europe –T.E.S.T. Program 2006

John L. Johnson, M. Hackel, D. Hoban, 2007 .

P1121 Patterns of susceptibility of Gram-negatives/positives isolated in the United Kingdom and Ireland

John L. Johnson, M. Hackel, D. Hoban, 2007 .

Comparative Analysis of Tigecycline in South America from 2004-2007

John L. Johnson, M. Hackel, D. Hoban, 2007 .

In Vitro Activity of Tigecycline and 13 Comparators against Pathogens from a Global Population of Intensive Care Patients in 2007

John L. Johnson, M. Hackel, D. Hoban, 2007 .

The In Vitro Activity of Tigecycline and 10 Comparators in a Global Population - T.E.S.T. Program 2006

John L. Johnson, A. Hsiung, D. Hoban, 2006 .

Tigecycline In Vitro Activity Against Often Difficult To Treat Pathogens From Centers In Asia/Pacific Rim - T.E.S.T. Program 2006

John L. Johnson, A. Hsiung, D. Hoban, 2006 .

Antibacterial activity of fortimicin A compared with those of five other aminoglycosides, and factors affecting susceptibility tests

R. Jones, A. Barry, C. Baker, 1981, Antimicrobial Agents and Chemotherapy.

Quality Control Limits for the Agar Overlay Disk Diffusion Antimicrobial Susceptibility Test

A. Barry, R. Badal, 1982, Journal of clinical microbiology.

Reliability of the microdilution technic for detection of methicillin-resistant strains of staphylococcus aureus.

A. Barry, R. Badal, 1977, American journal of clinical pathology.

Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria.

D. Paterson, P. Hsueh, D. Hoban, 2011, The Journal of infection.

Antimicrobial susceptibilities of aerobic and facultative gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014

B. Cao, Ziyong Sun, Qiwen Yang, 2017, BMC Infectious Diseases.

Reliability of early identifications obtained with Enterobacteriaceae-plus biochemical cards in the automicrobic system

A. Barry, R. Badal, 1982, Journal of clinical microbiology.

Sensitivity, specificity, and reproducibility of the automicrobic system (with the Enterobacteriaceae-plus biochemical card) for identifying clinical isolates of Gram- negative bacilli

A. Barry, R. Badal, T. Gavan, 1982, Journal of clinical microbiology.

Influence of inoculum growth phase on microdilution susceptibility tests

A. Barry, R. Badal, R. Hawkinson, 1983, Journal of clinical microbiology.

Antimicrobial Susceptibility Testing of Cefoperazone

Ronald N. Jones, A. Barry, C. Baker, 2003 .

Tentative interpretive standards for agar disk diffusion antimicrobial susceptibility testing of cefoperazone

R. Jones, A. Barry, C. Baker, 1982, Journal of clinical microbiology.

Short-Term Storage ofSixPenicillins andCephalothin in Microdilution Trays forAntimicrobial Susceptibility Tests

A. Barry, R. Badal, L. Effinger, 1976 .

Distribution of Extended-Spectrum β-Lactamases, AmpC β-Lactamases, and Carbapenemases among Enterobacteriaceae Isolates Causing Intra-Abdominal Infections in the Asia-Pacific Region: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART)

P. Hsueh, W. Sheng, R. Badal, 2013, Antimicrobial Agents and Chemotherapy.

Discrepancy between genotypic and phenotypic extended-spectrum β-lactamase rates in Escherichia coli from intra-abdominal infections in the USA.

K. Kazmierczak, D. Sahm, R. Badal, 2016, Journal of medical microbiology.

Evaluation of the Clinical and Laboratory Standards Institute phenotypic confirmatory test to detect the presence of extended-spectrum β-lactamases from 4005 Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae and Proteus mirabilis isolates.

I. Morrissey, M. Hackel, D. Hoban, 2014, Journal of medical microbiology.

Epidemiologic trends, occurrence of extended-spectrum beta-lactamase production, and performance of ertapenem and comparators in patients with intra-abdominal infections: analysis of global trend data from 2002-2007 from the SMART study.

D. Hoban, S. Hawser, S. Bouchillon, 2010, Surgical infections.

Emergence of High Levels of Extended-Spectrum-β-Lactamase-Producing Gram-Negative Bacilli in the Asia-Pacific Region: Data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 2007

D. Paterson, P. Hsueh, D. Hoban, 2009, Antimicrobial Agents and Chemotherapy.

Epidemiology and susceptibility of pathogens from SMART 2011–12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections

S. Unal, E. Alp, F. Tabak, 2017, The Journal of antimicrobial chemotherapy.

VET05-R : Generation, presentation, and application of antimicrobial susceptibility test data for bacteria of animal origin : A Report

R. Miller, P. McDermott, J. Turnidge, 2011 .

In Vitro Potency of Tigecycline Against Pathogens from Most Common Body Sites: A Study in Asia/Pacific Rim

M. Hackel, D. Hoban, J. Johnson, 2008 .

Tigecycline Comparison with Minocycline Resistance Pathogens. A Worldwide Perspective

John L. Johnson, M. Hackel, D. Hoban, 2008 .

A Global Evaluation of Vancomycin Resistant Enterococci (VRE) Against Tigecycline: The T.E.S.T. Program

John L. Johnson, M. Hackel, D. Hoban, 2008 .

Evaluation of Multidrug Resistant (MDR) Isolates Against Tigecycline: A Canadian Perspective

M. Hackel, D. Hoban, J. Johnson, 2008 .

Evaluation of 11 Antimicrobial Agents Against Australian Bacteremia Isolates: The T.E.S.T. Program

M. Hackel, D. Hoban, J. Johnson, 2008 .

Tigecycline and Comparators Against S. pneumoniae: A Global Study

M. Hackel, D. Hoban, J. Johnson, 2008 .

P1685 In vitro activity of tigecycline and 10 common therapeutic agents against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus species – Global Data, 2004 – 2006

John L. Johnson, M. Hackel, D. Hoban, 2007 .

Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii.

D. Hoban, D. Sahm, R. Badal, 2016, International journal of antimicrobial agents.

Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin

R. Jones, A. Barry, C. Baker, 1980, Antimicrobial Agents and Chemotherapy.

Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics

R. Jones, A. Barry, C. Baker, 1980, Antimicrobial Agents and Chemotherapy.

Sch 29482, a new oral penem: comparative in-vitro activity, beta-lactamase stability and inhibition.

R. Jones, A. Barry, C. Thornsberry, 1982, The Journal of antimicrobial chemotherapy.

Short-Term Storage of Six Penicillins and Cephalothin in Microdilution Trays for Antimicrobial Susceptibility Tests

A. Barry, R. Badal, L. Effinger, 1976, Antimicrobial Agents and Chemotherapy.

Fluoroquinolone Resistance Among Gram-Negative Urinary Tract Pathogens: Global Smart Program Results, 2009-2010

D. Hoban, S. Hawser, S. Bouchillon, 2012, The open microbiology journal.

Stability of minocycline, doxycycline, and tetracycline stored in agar plates and microdilution trays

A. Barry, R. Badal, 2007, Current Microbiology.

Etiology, Extended-spectrum &bgr;-lactamase Rates and Antimicrobial Susceptibility of Gram-negative Bacilli Causing Intra-abdominal Infections in Patients in General Pediatric and Pediatric Intensive Care Units—Global Data From The Study for Monitoring Antimicrobial Resistance Trends 2008 to 2010

M. Hackel, D. Hoban, S. Hawser, 2013, The Pediatric infectious disease journal.

Identification of Enterobacteriaceae in frozen microdilution trays prepared by Micro-Media Systems

A. Barry, R. Badal, L. Effinger, 1979, Journal of clinical microbiology.

In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli from patients with intra-abdominal infections worldwide from 2005-2007: results from the SMART study.

D. Hoban, S. Hawser, S. Bouchillon, 2009, International Journal of Antimicrobial Agents.

A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospital-associated intra-abdominal infections in China.

Y. Wang, B. Cao, Ziyong Sun, 2013, Journal of medical microbiology.

Trends in susceptibility of selected gram-negative bacilli isolated from intra-abdominal infections in North America: SMART 2005-2010.

M. Hackel, D. Hoban, S. Hawser, 2013, Diagnostic microbiology and infectious disease.

Surveillance of antimicrobial susceptibility of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in China: the 2002-2009 Study for Monitoring Antimicrobial Resistance Trends (SMART).

Ziyong Sun, Qiwen Yang, Yingchun Xu, 2010, International journal of antimicrobial agents.

Using Nucleic Acid Microarrays To Perform Molecular Epidemiology and Detect Novel β-Lactamases: a Snapshot of Extended-Spectrum β-Lactamases throughout the World

R. Bonomo, A. Hujer, M. Hackel, 2012, Journal of Clinical Microbiology.

Antimicrobial susceptibility of intra-abdominal Gram-negative bacilli from Europe: SMART Europe 2008

Y. Carmeli, D. Hoban, P. Hawkey, 2011, European Journal of Clinical Microbiology & Infectious Diseases.

Epidemiology and Antimicrobial Susceptibility of Gram-Negative Pathogens Causing Intra-abdominal Infections in Pediatric Patients in Europe—SMART 2011–2014

M. Hackel, D. Sahm, R. Badal, 2016, Journal of the Pediatric Infectious Diseases Society.

Diagnostic Microbiology and Infectious Disease

K. Kazmierczak, M. Hackel, D. Hoban, 2014 .

Antimicrobial susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in South African hospitals (SMART Study 2004-2009): impact of the new carbapenem breakpoints.

C. Feldman, K. Boffard, M. Veller, 2012, Surgical infections.

Antibiotic susceptibility of intra-abdominal infection isolates from Indian hospitals during 2008.

D. Hoban, S. Hawser, S. Bouchillon, 2010, Journal of medical microbiology.

Susceptibility of Klebsiella pneumoniae Isolates from Intra-Abdominal Infections and Molecular Characterization of Ertapenem-Resistant Isolates

N. Woodford, D. Livermore, M. Hackel, 2011, Antimicrobial Agents and Chemotherapy.

Epidemiology and Detect Novel β-Lactamases: a Snapshot of ESBLs

R. Bonomo, A. Hujer, M. Hackel, 2012 .

Susceptibility trends and molecular characterization of Gram-negative bacilli associated with urinary tract and intra-abdominal infections in Jordan and Lebanon: SMART 2011-2013.

W. Hayajneh, A. Hajj, R. Badal, 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Antimicrobial resistance and resistance mechanisms of Enterobacteriaceae in ICU and non-ICU wards in Europe and North America: SMART 2011-2013.

K. Kazmierczak, D. Sahm, R. Badal, 2015, Journal of global antimicrobial resistance.

Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicin.

R. Jones, A. Barry, C. Baker, 1979, The Journal of antibiotics.

In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study

S. Marcella, M. Motyl, R. Badal, 2016, Infectious Diseases and Therapy.

Reproducibility of three microdilution systems for identification of enterobacteriaceae, compared with API 20E and micro-ID test systems

A. Barry, R. Badal, L. Effinger, 2007, Current Microbiology.

Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013

B. Cao, Ziyong Sun, Qiwen Yang, 2015, Antimicrobial Agents and Chemotherapy.

Piperacillin susceptibility tests by the single-disk agar diffusion technique

R. Jones, A. Barry, C. Baker, 1979, Antimicrobial Agents and Chemotherapy.